Under these low-oxygen conditions, cancer cells release vascular endothelial growth factor A (VEGFA), which targets VEGF receptor 2 (VEGFR2) on adjacent endothelial cells (ECs) or on circulating endothelial progenitor cells derived from the bone marrow, thus initiating angiogenesis (148). Here, VEGFA is linked to cancer.